Guardian Pharmacy Services, Inc.
Every calculator, already run for GRDN
Open the full toolkit →You have the numbers on GRDN. Get the argument.
A written report on which of these readings actually decide the outcome for Guardian Pharmacy Services, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
7 analysts covering GRDNAnalyst Price Target Disagreement for Guardian Pharmacy Services, Inc.
Wall Street's bull case implies +28% from the current price; the bear case implies +16%. Analysts are relatively aligned on GRDN's range.
Ownership & short interest
Insider Trading Activity for GRDN
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine techno…
GRDN — frequently asked
Is GRDN a buy right now?
Wall Street's consensus rating on Guardian Pharmacy Services, Inc. is Strong Buy across 7 analysts, with a mean price target of $49.86 (+23% vs. the current $40.49). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is GRDN overvalued?
GRDN trades at 38.9x trailing earnings, against a DCF fair value of $40 per share. The current price implies 6% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is GRDN's next earnings date?
Guardian Pharmacy Services, Inc. is next scheduled to report earnings around Nov 9, 2026. A full GRDN research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Guardian Pharmacy Services, Inc.?
Analysts covering Guardian Pharmacy Services, Inc. (GRDN) range from a bear-case target of $47.00 to a bull-case high of $52.00, with a mean consensus target of $49.86 across 7 analysts. The spread of $5.00 (12% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Guardian Pharmacy Services, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Guardian Pharmacy Services, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full GRDN research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Guardian Pharmacy Services, Inc., in minutes. 3 free reports included with every account — no credit card required.